The ACTonHEART Study: Design of a Randomized Controlled Clinical Trial of Acceptance and Commitment Therapy for Cardiac Patients

Sponsor
Istituto Auxologico Italiano (Other)
Overall Status
Completed
CT.gov ID
NCT01909102
Collaborator
(none)
92
1
2
80
1.2

Study Details

Study Description

Brief Summary

The study will determine whether a brief intervention program based on Acceptance and Commitment Therapy can be effective for the reduction of modifiable risk factors and improvement of psychological well-being in patients referred to cardiac rehabilitation

Condition or Disease Intervention/Treatment Phase
  • Behavioral: ACT-based intervention
  • Behavioral: usual care
N/A

Detailed Description

The Acceptance and Commitment Therapy is a mindfulness-based intervention which efficacy has been proven in the treatment of depression and anxiety, in stress reduction and in the modification of health- related behaviors in patients with several physical conditions. The application of an acceptance-based program in cardiac patients has revealed high treatment satisfaction and initial evidences of effectiveness in increasing heart-healthy behaviour.

The purpose of the trial is to evaluate the efficacy of a brief group-administered program based on Acceptance and Commitment Therapy in improving patients' ability to address modifiable multiple cardiovascular risk factors and overall psychological well-being, compared with the usual care.

Study Design

Study Type:
Interventional
Actual Enrollment :
92 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
The ACTonHEART Study: a Randomized Controlled Clinical Trial of Acceptance and Commitment Therapy in Cardiac Patients
Study Start Date :
Aug 1, 2015
Actual Primary Completion Date :
Mar 1, 2022
Actual Study Completion Date :
Apr 1, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: ACT-based intervention

The ACT-based intervention integrates educational topics on heart healthy behaviours with mindfulness and acceptance training regarding difficult thoughts and feelings, clarification of health-related values and commitment to behave in the valued direction while contacting difficult experiences.

Behavioral: ACT-based intervention

Behavioral: usual care

Active Comparator: Usual care

Usual care is based on current guidelines for the long-term multi-disciplinary rehabilitation and prevention of cardiac patients.

Behavioral: usual care

Outcome Measures

Primary Outcome Measures

  1. Low-density lipoprotein (LDL)cholesterol [Baseline and 12 months]

    Change from baseline LDL cholesterol level

  2. Blood pressure [baseline and 12 months]

    Change from baseline resting blood pressure (the mean of 2 measures taken 2 minutes apart with a manual sphygmomanometer)

  3. Body Mass Index [baseline and 12 months]

    Change from baseline Body Mass Index. It is calculated as weight in kilograms divided by height in meters squared

  4. Psychological Well-Being [Baseline and 12 months]

    Change from baseline Psychological Well-Being. It will be measured by the Psychological General Well-Being Inventory. The PGWBI is a self-administered questionnaire composed by six sub-scales: anxiety, depression, positive well-being, self-control, general health and vitality. Higher scores indicate better health.

Secondary Outcome Measures

  1. Health-related quality of life [Baseline and 12 months]

    Change from baseline Health-related quality of life. The Short Form-36 questionnaire for evaluation of Quality Of Life is widely used and gives valuable information on Quality Of Life related to health. The patients' Quality Of Life will be assessed through the following eight fractions: physical function, physical role, general health, social function, experience of pain, mental health, emotional role and vitality.

  2. Dietary habits [Baseline and 12 months]

    Change from baseline dietary habits. They will be assessed through the Mediterranean diet score, a large-scale diet score based on the inherent characteristics of Mediterranean dietary pattern. Questions focused on the frequency of usual consumption of 11 main components of the Mediterranean diet (nonrefined cereals, fruits, vegetables, potatoes, legumes, olive oil, fish, red meat, poultry, full fat dairy products and alcohol).

  3. Physical activity [Baseline anf 12 months]

    Change from baseline physical activity. It will be measured by The International Physical Activity Questionnaire (IPAQ), a self-report questionnaire that assesses the number of days per week and the number of times per day an individual spends doing specific activities.

  4. Smoking cessation [At 1-year follow-up]

    Self-report of smoking status

  5. Adherence to medication [Baseline and 12 months]

    Change from baseline adherence to medication. The Modified Morisky Scale will be used. It is a eight-item self-reported measure of medication taking.

  6. Exercise capability [Baseline and 12 months]

    Change from baseline exercise capability. The exercise capability will be considered as the maximal power (in Watts) reached during an incremental bicycle stress test.

Other Outcome Measures

  1. Psychological inflexibility [Baseline and 12 months]

    Change from baseline psychological inflexibility. It will be measured through the Acceptance and Action Questionnaire-II, a self-report 10-item scale.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 70 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • having a current diagnosis of ischemic heart disease (IHD)

  • being affected by major modifiable cardiovascular risk factors that will be assessed through the INTERHEART Modifiable Risk Score.

Only subjects with a full score >9 will be included in the study.

  • between the ages of 18 and 70 years

  • fluency in spoken and written Italian language

  • expression of written informed consent.

Exclusion Criteria:
  • cognitive impairment

  • severe psychiatric disorders according to Diagnostic and Statistical Manual-IV TR criteria (APA, 2000).

Contacts and Locations

Locations

Site City State Country Postal Code
1 San Luca Hospital, Istituto Auxologico Italiano Milano Italy 20149

Sponsors and Collaborators

  • Istituto Auxologico Italiano

Investigators

  • Principal Investigator: Gianluca Castelnuovo, PhD, PsyD, Istituto Auxologico Italiano

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Gianluca Castelnuovo, PhD, Istituto Auxologico Italiano
ClinicalTrials.gov Identifier:
NCT01909102
Other Study ID Numbers:
  • 12032013
First Posted:
Jul 26, 2013
Last Update Posted:
Apr 5, 2022
Last Verified:
Apr 1, 2022
Keywords provided by Gianluca Castelnuovo, PhD, Istituto Auxologico Italiano
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 5, 2022